Showing 1-10 of about 52 articles.

Prolacta Bioscience

Prolacta’s 100% Human Milk-Based Fortifiers Lower the Risk of Multiple Complications and Death Among Preterm Infants, Compared to Fortifiers Made From Cow Milk, Says New Study

DUARTE, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of a new...

September 08, 2020

Prolacta Bioscience

Research Suggests Some Premature Infants May Go Home From the NICU Up To Three Weeks Earlier When Fed Prolacta’s 100% Human Milk-Based Nutritional Products; Those with Bronchopulmonary Dysplasia May Benefit the Most

DUARTE, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- A retrospective study indicates that premature infants’ stays in neonatal intensive care units (NICUs) are reduced anywhere from 4.5 to 22.9 days...

July 30, 2020 photo-release

Prolacta Bioscience

Multiple NICUs Showed Improved Growth & Lung Health in Premature Infants by Fortifying Feeds Safely in the First Days of Life with Prolacta’s 100% Human Milk-Based Fortifiers

DUARTE, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of an...

July 14, 2020

MiMedx Group, Inc.

MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings

Equity Financing Led by EW Healthcare Partners and Debt Financing Provided by Hayfin Capital Management EW Healthcare Partners Managing Director and Co-Founder Martin Sutter and Former Medtronic...

July 02, 2020

PreemieWorld

The Preemie Parent’s Survival Guide to the NICU Now Reflects the Latest Clinical Advancements to Better Support Parents Worldwide

WASHINGTON, June 24, 2020 (GLOBE NEWSWIRE) -- PreemieWorld and Prolacta Bioscience are proud to announce publication of the updated second edition of The Preemie Parent’s Survival Guide to the...

June 24, 2020

Prolacta Bioscience

Preterm Infants Fed Prolacta’s 100% Human Milk-Based Fortifiers Achieved Catch-Up Growth by Age 2 with Appropriate Neurodevelopmental Outcomes, Study Says

DUARTE, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of a...

June 01, 2020

Prolacta Bioscience

Head-to-Head Subgroup Analysis of Human Milk–Based Fortifiers Finds Significant Improvements in Health and Brain Growth Measure for Preemies Fed Mother’s Milk Plus Prolacta’s Fortifiers

DUARTE, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk–based nutritional products, announced today that a subgroup analysis...

May 12, 2020

Prolacta Bioscience

UPDATE - Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic

DUARTE, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience,® the world’s leading hospital provider of 100% human milk-based nutritional products, today notified hospital customers of the...

April 02, 2020

Prolacta Bioscience

Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic

DUARTE, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, today notified hospital customers of the...

April 02, 2020

Human Milk Science and Innovation Conference

La microbiota y el eje intestino-cerebro en neonatos prematuros: tema central de la conferencia ICHMSI de 2020

BARCELONA, Spain, Feb. 05, 2020 (GLOBE NEWSWIRE) -- La conferencia International Conference on Human Milk Science and Innovation (ICHMSI, por sus siglas en inglés) celebrará su primera edición...

February 05, 2020

Showing 1-10 of about 52 articles.

Search Results

Prolacta’s 100% Human Milk-Based Fortifiers Lower the Risk of Multiple Complications and Death Among Preterm Infants, Compared to Fortifiers Made From Cow Milk, Says New Study

Research Suggests Some Premature Infants May Go Home From the NICU Up To Three Weeks Earlier When Fed Prolacta’s 100% Human Milk-Based Nutritional Products; Those with Bronchopulmonary Dysplasia May Benefit the Most

Multiple NICUs Showed Improved Growth & Lung Health in Premature Infants by Fortifying Feeds Safely in the First Days of Life with Prolacta’s 100% Human Milk-Based Fortifiers

MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings

The Preemie Parent’s Survival Guide to the NICU Now Reflects the Latest Clinical Advancements to Better Support Parents Worldwide

Preterm Infants Fed Prolacta’s 100% Human Milk-Based Fortifiers Achieved Catch-Up Growth by Age 2 with Appropriate Neurodevelopmental Outcomes, Study Says

Head-to-Head Subgroup Analysis of Human Milk–Based Fortifiers Finds Significant Improvements in Health and Brain Growth Measure for Preemies Fed Mother’s Milk Plus Prolacta’s Fortifiers

UPDATE - Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic

Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic

La microbiota y el eje intestino-cerebro en neonatos prematuros: tema central de la conferencia ICHMSI de 2020

Newswire Distribution Network & Management

About Us